We investigated the permeability changes that occur in the human brain microvascular endothelial cell (HBMEC) monolayer, an in vitro model of the blood-brain barrier, during Escherichia coli K1 infection. An increase in permeability of HBMECs and a decrease in transendothelial electrical resistance were observed. These permeability changes occurred only when HBMECs were infected with E. coli expressing outer membrane protein A (OmpA) and preceded the traversal of bacteria across the monolayer. Cerebral microvascular endothelial cells are the principal component of the blood-brain barrier (BBB). Specific properties of brain microvascular endothelial cells, such as the presence of continuous tight junctions and low levels of endocytosis and transcytosis, are integral to their proper function. Disruption of the BBB leads to the pathophysiology of many central nervous system disorders, such as cerebral edema and ischemic brain damage. Cerebral edema is a characteristic pathophysiological feature of neonatal meningitis caused by a variety of gram-negative bacteria [1, 2] . Escherichia coli K1 is one of the leading cause of meningitis among
newborn infants. However, the mechanisms by which E. coli K1 disrupts the BBB and causes cerebral edema have not been identified.
Much progress has been made in the last decade in unraveling the molecular basis of E. coli K1 interactions with brain microvascular endothelial cells. Several surface molecules of E. coli have been shown to mediate its ability to invade human brain microvascular endothelial cells (HBMECs), although outer membrane protein A (OmpA) appears to be the major factor [3] [4] [5] [6] [7] [8] . OmpA interacts with a 95-kDa HBMEC glycoprotein to induce actin rearrangements in host cells, which results in internalization of bacterium [9, 10] . This OmpA receptor (endothelial cell glycoprotein [Ecgp] ) is specifically expressed in HBMECs, but not in systemic endothelial cells, which may be the basis for the neurotropic nature of E. coli K1. Other studies have shown that OmpA-mediated invasion of HBMECs also induces the activation of focal adhesion kinase and phosphatidyl inositol-3 kinase for actin rearrangements [11, 12] . In addition, the invading E. coli activates protein kinase C (PKC)-a, which recruits to the membrane of the infected cell at the actin condensation sites for ef-ficient internalization of E. coli [13] . At the surface of HBMECs, the phosphorylated PKC-a interacts with caveolin-1, a specific marker of caveolae, to pull the bacteria into HBMECs [14] . Overexpression of a dominant negative form of PKC-a completely abolished the actin condensation at the site of E. coli adherence and subsequently blocked the invasion of bacteria into HBMECs.
Actin filaments at the periphery of endothelial cells are linked to cell-to-cell adherence junctions [15] . These junctions are formed by transmembrane calcium-dependent adhesive proteins (cadherins), which are associated with a complex network of cytoskeletal proteins inside cytoplasm that, in turn, promote anchorage to actin filaments. Vascular-endothelial cadherin (VEC; cadherin-5) is an endothelium-specific cadherin that forms a complex with b-catenin via the cadherin domain. bcatenin binds to a-catenin, which, in turn, interacts with actin filaments. Thus, b-catenin serves as a linker molecule to cadherin and actin. VEC-based adhesion may be influenced by a wide range of extracellular signals, including growth factors, suggesting a role for a wide range of signaling pathways. PKC has been implicated in modulating VEC by using a combination of pharmacological agonists and antagonists [16] . PKC-a-mediated phosphorylation of VECs regulates the shifts in intracellular pools of cadherin/catenins. Current evidence suggests that the classic PKC-a isoform regulates the increase in endothelial permeability [17] . Because increased phosphorylation of PKC-a is associated with E. coli invasion of HBMEC, we speculated that phospho-PKC-a might modulate the permeability of the BBB.
In the present report, we show that OmpA-positive (OmpA + ) E. coli increase the permeability of the HBMEC monolayer with a concomitant decrease in transendothelial electrical resistance. OmpA + E. coli affect the HBMEC permeability by disrupting VEC interactions at the tight junctions. Immunoprecipitation studies of OmpA + E. coli-infected HBMEC lysates suggest that b-catenin was dislodged from VEC. This disassembly was completely abolished in HBMECs overexpressing a dominant negative form of PKC-a. Antibodies to OmpA and its receptor, Ecgp, significantly blocked E. coli-induced permeability changes. To our knowledge, this is the first report to show that direct interaction of E. coli K1 with HBMEC causes an increase in the BBB permeability.
MATERIALS AND METHODS

Bacteria.
A rifampin-resistant mutant of E. coli K1 strain RS 218 (serotype O18:K1:H7), E44 (OmpA + E. coli), was originally isolated from the cerebrospinal fluid of a neonate with meningitis; it invades HBMECs in vitro and in vivo [3] . E91 is a noninvasive derivative of E44, in which the ompA gene was disrupted, and is designated as OmpA Ϫ E. coli. E91 was transformed with pUC19 containing the entire ompA gene and pUC19 plasmid alone to obtain E105 (pOmpA + E. coli) and E111 (pUC19 Ϫ E. coli), respectively [3] . HB101 is a laboratory E. coli strain. The bacteria were grown in brain-heart infusion broth with appropriate antibiotics as necessary. Cryptococcus neoformans strains TYC645 and B4500 were obtained from Dr. A. Jong (Children's Hospital, Los Angeles) and grown in yeastpeptone-dextrose medium. All bacterial media were purchased from Difco Laboratories.
Materials.
Monoclonal antibodies to phospho-PKC-a were purchased from Cell Signaling Technology. Antibodies to VEC and b-catenin were obtained from Transduction Laboratories. Thrombin was obtained from Enzyme Research Laboratories. Normal goat serum and Vectashield mounting medium with 4 ,6-diamidino-2-phenylindole were obtained from Vector Laboratories. The PepTag nonradioactive PKC-a assay was purchased from Promega. SuperSignal chemiluminescence reagent was obtained from Pierce. All other chemicals were obtained from Sigma. A cell-permeable PKC peptide was purchased from Calbiochem, and an unrelated peptide that contains antennapedia sequence was synthesized as described elsewhere [14] .
HBMEC culture maintenance and transfections. HBMECs were isolated and cultured as described elsewhere [3] . Primary HBMEC cultures (passage 12-16) were maintained in RPMI 1640 medium containing 10% heat-inactivated fetal bovine serum, 10% Nu-serum, 2 mmol/L glutamine, 1 mmol/L sodium pyruvate, 100 mg/mL streptomycin, 100 U/mL penicillin, essential amino acids, and vitamins. HBMECs were transfected with mammalian expression vectors containing wild-type PKCa or a dominant negative form of PKC-a by lipofectamine [13] . In brief, DNA-lipofectamine in RPMI 1640 medium was added to 30%-40% confluent HBMEC monolayers. After 6 h of incubation at 37ЊC, the cells were washed with RPMI 1640 medium, and complete medium was added. The next day, the medium was replaced with a medium containing G418, and these cells were maintained in the same medium until they were confluent. Human umbilical vein endothelial cells (HUVECs) were obtained from Clontech and maintained in the medium provided by the manufacturer.
Transendothelial permeability assay. The passage of horseradish peroxidase (HRP) through confluent monolayers was measured with transwell cell culture chambers (polycarbonate filters, 3.0-mm pore size; Costar). HBMECs were seeded at cells/filter in 200 mL of RPMI 1640 medium, as 4 2 ϫ 10 described for HBMEC culture [3] . The lower compartment was filled with the same medium (800 mL). HBMEC were grown for 3-4 days to attain confluence.
At the beginning of the experiment, the medium in the upper compartment was carefully removed and replaced with 200 mL of fresh medium or medium containing either the appropriate number of bacteria or thrombin (1 mg/mL) along with 0.1 mg of HRP. At this point, the lower compartment was also refilled with fresh medium. At several time points, 5-mL samples were withdrawn from the lower compartment. The HRP concentration was determined spectrophotometrically at 470 nm to determine the peroxidase activity with 5 mmol/L guaiacol in 50 mmol/L Na 2 H 2 PO 4 in the presence of 0.7 mmol/L hydrogen peroxide. In addition, at every time point, the transendothelial electrical resistance (TER) was measured with a Millipore ERS apparatus, according to manufacturer's protocol. In some experiments, the monolayers were incubated with either the cellpermeable PKC-a peptide or a scrambled peptide (4 mmol/L) for 6 h, gently washed, and used for HRP clearance assays. At various time periods, endothelial cell injury was assessed by trypan blue dye exclusion [3] .
Preparation of cell lysates, immunoprecipitations, and Western-blot analysis. Confluent cell cultures in 100-mmdiameter dishes were incubated at 37ЊC with either OmpA + E. coli (E44) or OmpA Ϫ E. coli (E91), for varying periods of time.
The cells were then rinsed with ice-cold PBS and scraped off into 500 mL of RIPA buffer (PBS, 1% Nonidet P-40, 0.5% sodium deoxycholate, 0.1% SDS, 10 mg/mL phenylmethyl sulfonyl fluoride, 2 mmol/L aprotinin, and 1 mmol/L sodium orthovanadate). The cells were disrupted mechanically by sonication, followed by centrifugation for 10 min at 5000 g to remove cell debris. The supernatants were used as cell lysates. For immunoprecipitations, the cell lysates (300 mg of protein) were incubated with the respective antibody at 4ЊC overnight. The immune complexes were incubated with Protein A agarose beads for 1 h at 4ЊC, washed 3 times in ice-cold lysis buffer, and boiled in 30 mL of SDS-PAGE sample buffer. The samples were separated on either 10% or 12% SDS polyacrylamide gels. For Western-blot analysis, ∼30 mg of total cell lysates was separated by electrophoresis on a 8% SDS polyacrylamide gel, and the proteins were transferred to nitrocellulose. The blots were blocked in blocking buffer (100 mmol/L Tris-Cl [pH 7.5], 150 mmol/L NaCl, 0.1% Tween20, 3.0% bovine serum albumin, or 5% nonfat milk) and then probed with the appropriate antibody. The same blot was stripped with a stripping solution (Pierce) and reblocked for subsequent probing with additional antibodies. The immunoreactive proteins were detected with a chemiluminescence detection kit (Super Signal Chemiluminescence kit; Pierce). The protein bands on the X-ray films were quantitated on a Bio-Rad densitometer by Alpha-imager software (Alpha Innotech).
PepTag assay for nonradioactive detection of PKC-a activity. The PepTag assay uses a florescent peptide substrate that is highly specific to PKC-a (Promega). Phosphorylation by PKC-a changes the net charge of the substrate from +1 to 1, thereby allowing the phosphorylated and nonphosphorylated versions of the substrate to be separated on an agarose gel (0.8%). The phosphorylated species migrates toward the positive electrode, whereas the nonphosphorylated substrate migrates toward the negative electrode. The phosphorylated peptide in the band can then be visualized under UV light. For the PKC-a assay, HBMEC total lysates or membrane proteins (10-25 mg in 10 mL) were incubated with PKC reaction mixture (25 mL), according to the manufacturer's protocol, at 30ЊC for 30 min, as described elsewhere [13] . The reactions were stopped by placing the tubes in a boiling water bath. After adding 80% glycerol (1 mL), the samples were loaded onto an agarose gel (0.8% agarose in 50 mmol/L Tris-HCl [pH 8.0]) and were separated in the same buffer at 100 V for 15 min. The bands were visualized under UV light and photographed.
Immunofluorescence staining. HBMECs were grown in 8-well chamber slides coated with collagen and were infected with E. coli, as described above. The monolayers then were washed with PBS and were fixed in 2% paraformaldehyde for 15 min at room temperature. Subsequently, the monolayers were incubated with 5% normal goat serum in PBS containing 1% Triton X-100 (NGS/PBST) for 30 min and were further incubated with primary antibody in NGS/PBST for 1 h at room temperature. The cells were then washed with PBS and incubated with secondary antibodies conjugated to the fluorochromes Cy3 and fluorescein isothiocyanate, respectively, for 30 min at room temperature. The cells were washed again, the chambers were removed, and slides were mounted in Vectashield (Vector Laboratories) antifade solution containing 4 ,6-diamidino-2-phenylindole. Cells were viewed with a Leica DMRA microscope with Plan-apochromat ϫ40/1.25 NA and ϫ63/1.40 NA oil immersion objective lenses. Image acquisition was done with a SkyVision-2/VDS digital charge-coupled device (12-bit, pixel) camera in unbinned or -1280 ϫ 1024 2 ϫ 2 binned models into EasyFISH software, and images were saved as 16-bit monochrome and merged as 24-bit TIFF images (Applied Spectral Imaging). The images were assembled and labeled by Adobe PhotoShop.
Statistical analyses. Statistical comparisons were made using the 2-tailed Student's t test. Values are reported as and were considered to be significant at . means ‫ע‬ SD P ! .05 The assays were repeated at least 2 or 3 times in triplicates.
RESULTS
OmpA
+ E. coli invasion of HBMECs increases the permeability of the HBMEC monolayer.
Other studies suggested that OmpA of E. coli interacts with HBMECs and activates several signaling pathways, including that of PKC-a [13] . Thus, we examined whether the presence of OmpA is responsible for the increased permeability of the HBMEC monolayer in vitro. Endothelial cell monolayers were grown on filters and incubated with 2 different inocula of bacteria (MOI) along with HRP. At In some experiments, cells were treated with thrombin or bovine serum albumin (1 mg/mL). C, Human umbilical vein endothelial cells were seeded in transwell inserts and cultured until they attained confluence. The cells were then infected with cfu (200 mL) of either OmpA + or OmpA Ϫ E. coli or were treated with thrombin (1 mg/mL). In 6 1 ϫ 10 all these experiments, 5 mL of medium from the lower chamber was taken at varying periods of time, and peroxidase activity was estimated as described in Materials and Methods. HRP activity was expressed as picograms per well and is an average of 3 separate experiments performed in triplicate. Error bars represent SDs from the means.
varying periods of time, 5 mL of medium from the bottom chamber was removed, and the peroxidase activity was estimated by a colorimetric assay. As shown in figure 1A, coli caused no such increase in HRP clearance (figure 1B).
Incubation of HBMECs with pOmpA + E. coli induced a 4.5-fold increase in HRP leakage ( ng/well), compared 9.5 ‫ע‬ 1.0 with incubation with pUC19 Ϫ E. coli ( ng/well) ( 1.8 ‫ע‬ 0.7 P ! ) at 120 min after infection, demonstrating that OmpA .001 expression is necessary for increased HBMEC monolayer permeability. Because thrombin has been shown to induce a profound alteration in endothelial cell monolayer permeability, we used thrombin in our assays as a positive control. Thrombin treatment of HBMECs increased permeability to HRP at a very early time point (15-30 min), whereas the control protein (bovine serum albumin) showed no such increase in HRP leakage. The HRP clearance induced by thrombin ( ng/well) 12 ‫ע‬ 1.5 was 30% more than that induced by OmpA + E. coli (9.0 ‫ע‬ ng/well) at 120 min after infection. In addition, the HBMEC 1.0 monolayers were also incubated with C. neoformans (10 6 organisms/transwell), to examine the ability of this fungus to induce permeability changes. As shown elsewhere [18] , this pathogen caused no increase in HRP clearance under similar experimental conditions as those of OmpA + E. coli, suggesting that the HBMEC permeability changes are specific to OmpA
Another study showed that E. coli K1 invaded HBMECs significantly more than it invaded nonbrain endothelial cells, such as HUVECs and human aortic endothelial cells [3] . Thus, we also examined the effect of OmpA + E. colion HUVEC monolayer permeability. Thrombin treatment of HUVECs was also used as a positive control. OmpA + E. coli did not elicit any HRP clearance across HUVECs until 60 min after infection; however, it caused a slight increase at 90 min ( figure 1C) figure 2C ). Thrombin treatment, however, caused ∼60% decrease in TER in both HBMECs and HUVECs, compared with untreated cells. These results are in good agreement with HRP clearance data, suggesting that OmpA expression is important for increased permeability of HBMECs.
Permeability of the HBMEC monolayer precedes transcytosis of OmpA + E. coli and is reversible after invasion. Previous studies have shown that OmpA + E. coli invade HBMECs at a frequency of 0.1% of the total inoculum at ∼90 min after infection [3] . In contrast, the increase in HRP clearance was observed from 30 min after infection, suggesting that the permeability of the monolayer occurs much earlier than the completion of invasion. To determine the relationship between permeability and invasion, we performed transcytosis assays with both OmpA + and OmpA Ϫ E. coli. As shown in figure 3A , significant numbers of OmpA + E. coli began traversing HBMEC only after 60 min of infection. Approximately 0.15% of the total OmpA + E. coli added in the upper chamber was recovered from the lower chamber. However, further increases in the inoculum showed decreases in the percentage of bacteria traversing the monolayer, suggesting that receptors could have been saturated at a 10:1 bacteria:cell ratio. Very few numbers of OmpA Ϫ E. coli traversed HBMECs in these experiments, even at an MOI of 10.
To further examine whether the permeability changes can be reversed after transcytosis of OmpA + E. coli, HBMEC monolayers were infected with the bacteria for 60 min, followed by removal of nonadherent bacteria and continued incubation in fresh experimental medium containing gentamicin (10 mg/mL) for another 4 h. After every 2 h of incubation, the transwell was transferred to a new well containing fresh experimental medium, and both TER and HRP clearance were measured. 1 ϫ 10 horseradish peroxidase without bacteria were taken as control. In separate experiments, both these cell layers were also treated with thrombin (1 mg/mL). At varying periods of time, TER was measured and expressed as means ‫ע‬ SD of at least 2 separate experiments carried out in triplicate. BSA, bovine serum albumin; pOmpA + E. coli, E. coli complemented with pUC19 expressing the ompA gene; pUC19 Ϫ E. coli, OmpA Ϫ E. coli containing the empty pUC19 alone.
We observed a significant drop of TER and increase in HRP leakage until 120 min after infection, followed by a recovery phase over the next 120 min (figure 3B). These results suggest that the HBMEC integrity returns to normal after the bacteria cross the monolayer. After 4 h of incubation in antibiotic medium, the monolayers were carefully washed once with RPMI 1640 medium and were infected again with the bacteria. After the second 120 min after infection, a significant decrease in TER and an increase in HRP leakage were observed, suggesting that E. coli invasion is responsible for HBMEC monolayer permeability increase. We also used HUVECs for these studies and observed no significant transcytosis even after 180 min after infection (data not shown).
PKC-a activated by invasive OmpA + E. coli interacts with VECs. Our previous studies have shown that OmpA + E. coli induces PKC-a activity within 10 min of infection, which decreases significantly by 60 min [13] . Because PKC-a has been implicated in BBB permeability by its interaction with VECs, we examined whether PKC-a associates with VEC using immunoprecipitation. Total cell lysates of HBMECs infected with either OmpA + or OmpA Ϫ E. coli were immunoprecipitated with anti-VEC antibody, followed by immunoblotting with antiphospho-PKC-a antibody. As shown in figure 4 , we observed significant association of phospho-PKC-a with VEC in only OmpA + E. coli-infected HBMECs, but not in OmpA Ϫ E. coliinfected cells. This association peaked between 15 and 30 min, followed by a decline at 60 min. This decrease was not due to unequal loading of immune complexes, because there were similar levels of VEC in all the lanes. Densitometric analysis of the bands in the blots indicated that there was a 5-fold increase 1 ϫ 10 medium. At this point, each medium in the inserts was replaced with the medium containing gentamicin (10 mg/mL). These inserts were transferred to wells containing new medium after every time point for 4 h. The monolayers were then washed gently and infected again with OmpA + E. coli to continue the incubation for 2 h longer. Both HRP clearance rates and TER were measured throughout the experiment. The data represent the mean from 2 separate experiments carried out in triplicate. Arrows, time of reinfection. values ‫ע‬ SD in the phospho-PKC-a associated with VEC 15-30 min after infection with OmpA + E. coli, compared with cells infected for 10 min (data not shown). In contrast, OmpA Ϫ E. coli showed no such increase in association of phospho-PKC-a with VEC at any time period. Thrombin treatment of HBMECs also revealed significant association of PKC-a with VEC, starting at 10 min and decreasing by 50% at 60 min. VEC interacts with b-catenins to maintain the cytoskeletal framework at the tight junctions of HBMEC monolayers. Thus, we also examined the association of b-catenins with VEC in the same immune complexes described above by reprobing the blot with an anti-b-catenin antibody. The blot showed decreased interaction of b-catenins with VEC between 15 and 60 min during OmpA + E. coli infection of HBMEC. However, this association was intact in HBMECs infected with OmpA Ϫ E. coli and in uninfected HBMECs (0-min time). These results suggest that infection of HBMECs with OmpA + E. coli leads to the activation of PKC-a, which in turn interacts with VEC. Interestingly, the OmpA + E. coli-infected cell lysates showed significant disassociation of b-catenins from VEC even after phospho-PKC-a was no longer detectable. These results suggest that reassembly of b-catenins with VEC might take some time, which results in continuous leakage of HRP through the HBMEC monolayer over this period. A similar dissociation of b-catenins from VEC was also observed in thrombin-treated HBMEC lysates.
OmpA + E. coli disrupts the tight junctions of the HBMEC monolayer. To confirm that OmpA + E. coli affects VEC at the tight junctions in HBMECs, immunocytochemistry was performed on monolayers infected with either OmpA + or OmpA Ϫ E. coli or monolayers treated with thrombin using anti-VEC antibody. As shown in figure 5 , the untreated cells showed continuous tight junctions in all the cells (figure 5E); however, when infected with OmpA + E. coli, redistribution of VEC was observed. The antigen was redistributed in a zigzag pattern that corresponded to intracellular gaps (figure 5F). Interestingly, the redistribution of VEC was observed only near regions of bacterial invasion, suggesting that a gradient of phospho-PKC-a might exist in the cell, interacting with VEC at the E. coli invasion site. The pattern of distribution did not change with further incubation. In contrast, the HBMECs infected with OmpA Ϫ E. coli showed no such damage to the tight junctions, despite the presence of several bacteria (figure 5G). Thrombin treatment showed complete disruption of the tight junctions; however, the breakdown of tight junctions is uniform throughout the monolayer ( figure 5H ). The infected monolayers were also stained with an anti-bcatenin antibody, to examine the distribution of the b-catenins. In agreement with VEC staining, b-catenin staining was also present at all the tight junctions in untreated cells (figure 5M). The OmpA + E. coli infected cells showed diffuse staining of bcatenins in the cytoplasm and away from cell-cell junctions ( figure 5N ). In contrast, OmpA Ϫ E. coli-treated HBMECs showed intact localization of b-catenins (figure 5O). As a positive control, we also stained HBMECs treated with thrombin with anti-b-catenin antibody, which showed significant migra- tion of b-catenins from cell boarders to the cytoplasm ( figure  5P ). Taken together, these results suggest that VEC interaction with b-catenin was disrupted in OmpA + E. coli-infected HBMECs and correlates well with the immunoprecipitation studies.
Inhibition of PKC-a activation induced by OmpA + E. coli blocks the increased permeability of HBMEC monolayers. After establishing that OmpA + E. coli-induced PKC-a activation was responsible for increased permeability of HBMECs, we next examined whether blocking PKC-a activation would abrogate E. coli-induced permeability. For this experiment, we used a cell-permeable peptide of PKC-a (IP-PKC; a 10-aa peptide), which resembles the pseudosubstrate sequence of PKCa and blocks the translocation of the activated PKC-a to the membrane. An unrelated peptide, coupled to antennapedia sequence, was used as a control peptide. The antennapedia sequence facilitates the entry of the peptide into HBMECs, as demonstrated elsewhere [14, 22] . The HBMEC monolayers were incubated with either IP-PKC for 1 h or with control peptide (4 mmol/L) for 4 h before infecting the HBMECs with the bacteria. Both the leakage of HRP and the TER changes were measured at varying time periods. OmpA + E. coli-induced leakage of HRP in IP-PKC treated HBMECs was significantly reduced ( ng/well), compared with either untreated 1.5 ‫ע‬ 0.5 cell or control peptide treated cells ( ng/well) ( 9.0 ‫ע‬ 1.0 P ! ) ( figure 6A ). In agreement with the permeability changes, .001 the TER of IP-PKC-treated HBMECs did not change significantly ( Q/cm 2 ), even after 120 min after infection, 275 ‫ע‬ 20 compared with control peptide-treated HBMECs ( Q/ 160 ‫ע‬ 22 cm 2 ) ( ). These results suggest that inhibition of PKC-P ! .001 a activation abrogates the E. coli-induced permeability.
To further demonstrate the role of PKC-a in E. coli-induced permeability changes, we transfected the HBMECs with a dominant negative construct of PKC-a (PKC-CAT/KR). In this construct, the catalytic domain of PKC-a is deleted, and the protein produced acts as a dominant negative [13] . HBMECs transfected with wild-type PKC-a were used as control. The PKC-CAT/KR-transfected HBMECs showed significantly less leakage of HRP when infected with OmpA + E. coli ( ng/well), 2.0 ‫ע‬ 0.8 whereas either nontransfected HBMECs or wild-type PKC-atransfected HBMECs exhibited the increased leakage of HRP ( ng/well) ( ) ( figure 6B) . Similarly, the TER of 8.5 ‫ע‬ 1.4 P ! .001 PKC-CAT/KR-transfected HBMECs remained at levels similar to that of uninfected HBMECs. In contrast, wild-type PKC-atransfected HBMECs infected with OmpA + E. coli showed a significant decrease in TER, similar to that of nontransfected HBMECs ( figure 6C ).
Because the disruption of tight junctions is associated with the OmpA + E. coli-induced permeability increase in HBMEC monolayers, we also examined the integrity of tight junctions in PKC-CAT/KR-transfected HBMECs by immunocytochemistry. As shown in figure 7 , the tight junctions in PKC-CAT/ KR-transfected HBMECs were not altered, despite infection with OmpA + E. coli ( figure 7C and 7D ). In contrast, wild-type PKC-a-transfected HBMECs showed loosening of tight junctions when stained with VEC, similar to the staining observed in nontransfected cells ( figure 7A and 7B) . In addition to VEC, we also stained the cells with anti-b-catenin antibody. These results are similar to those obtained with VEC, because bcatenins disassociate from VEC as a result of PKC-a interaction. The pattern of b-catenin staining in PKC-CAT/KR-transfected HBMECs infected with OmpA + E. coli was similar to that of uninfected HBMECs (figure 7G and 7H) when compared with wild-type PKC-a-transfected HBMECs ( figure 7E and 7F) . In addition to immunocytochemistry, intact association of b-catenins was also examined by immunoprecipitation studies in PKC-CAT/KR-transfected HBMECs. Cell lysates were immunoprecipitated with anti-VEC antibody, followed by blotting with anti-phospho-PKC-a and anti-b-catenin antibodies. The results showed that an increased association of PKC-a between 10 and 30 min after infection with VEC in wild-type PKC-atransfected HBMECs, whereas overexpression of PKC-CAT/KR in HBMECs completely blocked this association ( figure 8 ). In addition, the association of b-catenins with VEC in PKC-CAT/ KR-transfected HBMECs was not disrupted by OmpA + E. coli infection, whereas, in wild-type PKC-a-transfected HBMECs, b-catenins showed decreased association with VEC between 15 and 60 min after infection. Taken together, these data strongly suggest that activated PKC-a is responsible for the interaction with VEC, followed by a dislodging of b-catenin molecules that results in the loosening of HBMEC monolayers.
Anti-OmpA and anti-Ecgp antibodies inhibit OmpA + E. coli-induced leakage of the HBMEC monolayer. Previous studies have shown that OmpA of E. coli interacts with a receptor, Ecgp, on HBMECs for invasion [9] . In addition, overexpression of Ecgp enhances the invasion of E. coli into generally noninvasive cells, suggesting that Ecgp plays a role in E. coli invasion. Thus, we examined the effects of both anti-OmpA and anti-Ecgp antibodies on E. coli-induced increase in the permeability of the HBMEC monolayer. OmpA + E. coli was treated with either anti-OmpA antibody or control antibody leakage by 55% ( ng/well; ). In agreement with 4.0 ‫ע‬ 0.7 P ! .01 permeability changes, the decrease in TER was significantly inhibited in HBMECs by both antibodies. In contrast, control antibody-treated HBMECs showed a considerable decrease in TER when infected with OmpA + E. coli, which corresponded to an increased permeability of the monolayer ( figure 9B ). In addition, we also examined the disruption of VEC at the tight junctions, by immunocytochemistry, and the association of bcatenin with VEC. Immunostaining with an anti-VEC antibody showed no disruption of VEC staining when the OmpA + E. coli were treated with anti-OmpA antibody, whereas anti-Ecgp antibody showed only partial protection (similar to the PKC mutant; figure 7 ). In the case of anti-Ecgp antibody, the number of cell-cell junction gaps were reduced by 150%, compared with control antibody-treated HBMECs.
To examine the effects of these antibodies on PKC-a activation, we used the PepTag assay to measure the PKC-a activity in total cell lysates of HBMECs infected with OmpA + E. coli after antibody treatments. PKC-a activity was significantly elevated in HBMECs infected with OmpA + E. coli alone between 10 and 15 min after infection and started declining by 30 min ( figure 9C ). In contrast, both anti-OmpA and anti-Ecgp antibody-treated HBMEC lysates showed a significant decrease in the activation of PKC-a induced by OmpA + E. coli. These results suggest that the antibodies blocked the activation of PKC-a in HBMECs by inhibiting the interaction of OmpA + E. coli with HBMECs. Immunoprecipitation analyses of antibodytreated HBMEC lysates were also done with anti-VEC antibody, followed by Western blotting with anti-phospho-PKC-a and anti-b-catenin antibodies. As shown in figure 9D , negligible amounts of phospho-PKC-a were immunoprecipitated with anti-VEC antibody in the lysates of both treatments. The antiOmpA antibody was very effective in abolishing the PKC-a activation induced by E. coli. Consequently, we observed similar levels of b-catenin association with VEC at all time points, suggesting that anti-OmpA and anti-Ecgp antibody treatment protect HBMECs from OmpA + E. coli-induced disruption of tight junctions.
DISCUSSION
Vascular endothelial dysfunction is an important pathophysiological feature in neonatal meningitis caused by E. coli K1. Although cytokines and chemokines have been shown to contribute to BBB leakage, the direct effects of E. coli K1 on vascular endothelial integrity have not been studied. Here, we show that E. coli invasion of HBMECs, an in vitro model of the BBB, increases the permeability of HBMEC monolayer. We focused our studies on the first 2 h of infection for the following reasons: first, the invasion of OmpA + E. coli was optimal at 90 min [3] ; second, PKC-a activation occurs between 10 and 30 min after infection of HBMECs [13] ; and third, meningitis occurs within 2 h of intracardiac inoculation of E. coliK1 in the newborn rat model of infection [23] . In agreement with the above observations, OmpA + E. coli induced a significant increase in the permeability of HBMEC monolayers within 2 h after infection, which is associated with a significant drop in TER. Interestingly, the permeability increase and TER decrease induced by OmpA + E. coli occurred more slowly than the changes induced by thrombin. This delayed response could reflect the time required for E. coli to induce the signals necessary for invasion and subsequent interaction with tight junction molecules. In addition, although thrombin treatment induced a similar increase in permeability in both HBMECs and HUVECs, OmpA + E. coli induced a dramatic increase in permeability only in HBMECs but not in HUVECs, suggesting a specific interaction between E. coli and HBMECs.
These data are in good agreement with the results of another study, in which it was shown that E. coli invades HBMECs at much more significant levels than it does HUVECs [3] . Recently, it was shown that HBMECs express a specific receptor (Ecgp) that interacts with OmpA for invasion, whereas HUVECs do not express this receptor [9] . Confirming the specificity of OmpA Ϫ Ecgp interaction, both anti-OmpA and antiEcgp antibodies significantly blocked permeability changes in the infected HBMEC monolayer. Of these 2 antibodies, the anti-OmpA antibody showed a dramatic inhibitory effect on HRP clearance and TER decrease. The anti-Ecgp antibody, which only partially inhibited the invasion of E. coli, also showed only partial inhibition of HRP clearance. It is possible that some of the epitopes recognized by this antibody may be 10 , although no further increase was observed with higher numbers of bacteria. These results indicate that the receptor structures might be saturated at the 10:1 bacteria:endothelial cell ratio. Despite significant change in TER, only 0.15% of the total bacteria added crossed the HBMECs, indicating that OmpA + E. coli may be traversing HBMECs through a transcellular pathway, rather than a paracellular pathway. It could be that the gaps formed by the disruption of tight junctions might not be big enough for E. coli to pass paracellularly. A previous transmission electron microscopy study revealed that E. coli invades HBMEC monolayer transcellularly, supporting our current data [24] . Interestingly, Streptococcus pneumoniae, another pathogen that causes meningitis, invades HBMECs without significantly affecting cell-cell tight junctions, as shown by the absence of TER changes [25] . The invasion of S. pneumoniae into HBMECs has been shown to be mediated via the PAF receptor [26] . Similar to that of S. pneumoniae, C. neoformans invasion of HBMECs also did not alter HBMEC permeability, as shown in the present report and by other investigators [18] , suggesting that changes in HBMEC permeability could be specific to E. coli K1. In contrast to the mechanism used by E. coli to alter the BBB permeability, Chlamydia pneumoniae infection of HBMECs decreases the expression of occludin and increases the expression of VEC and b-catenins [27] . However, no data have been presented on the permeability of the monolayer under these conditions.
Several investigators have reported that activation of PKCa contributes to the thrombin-induced increase in permeability of endothelial cells [17, 20, 28] . Our previous study showed that E. coli invasion of HBMECs induces the activation of PKCa 10-30 min after infection [13] . In the present study, we found that activated PKC-a interacts with VEC to disassemble the tight junctions. This interaction increases the permeability of HRP and decreases TER of HBMEC monolayer. Interestingly, the disruption of the cell-cell junctions by E. coli is not uniform, unlike thrombin-treated HBMECs, suggesting that only HBMECs invaded by OmpA + E. coli are affected. It is possible that the phospho-PKC-a polarizes toward the invading E. coli and to the adjacent tight junctions, rather than distributing throughout the cell, resulting in local disruption of the cellcell junction. In addition, immunoprecipitation studies revealed that the disassembly of tight junctions is the result of the disassociation of b-catenins from VEC. The dissociation of VEC is reversible when the external bacteria were killed with antibiotics, indicating that, once the bacterium is inside the cell, the VEC assembly recovers slowly at some point within the next 2 h. In contrast, recovery from the permeability changes induced in endothelial cells by thrombin has been shown to take several hours [28] .
PKC-a is partially responsible for the phosphorylation of myosin light chain (MLC) in thrombin-treated cells. In contrast, it was shown elsewhere that OmpA + E. coli invasion is also dependent on MLC phosphorylation but independent of PKC-a activity [29] . Therefore, PKC-a activated by OmpA + E. coli directly interacts with VEC to disrupt the tight junctions, rather than activating MLC. In addition to VEC interactions, the tight junctions consist of the transmembrane protein occludin in association with several cytoplasmic proteins, such as ZO-1, that establish a link with actin filaments [30, 31] . Interestingly, phospho-PKC-a also regulates the activity of occludin by activating a phosphatase, which, in turn, contributes to the permeability of endothelial cells [32] . Studies are currently in progress to establish the relative contribution of occludin in E. coli-induced HBMEC permeability.
In summary, we have demonstrated that OmpA on E. coli binds to Ecgp on the surface of HBMECs. This binding activates PKC-a, which results in disassociation of b-catenin from VEC and leads to a temporary breakdown of the tight junctions and an increase in vascular permeability. Studies are in progress to determine whether OmpA + E. coli causes BBB breakdown in the newborn rat model of hematogenous meningitis. If so, can anti-OmpA and anti-Ecgp antibodies protect against this pathophysiological condition?
